Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-25 @ 1:02 PM
NCT ID: NCT05062759
Description: None
Frequency Threshold: 5
Time Frame: From the date of the first dose of study drug, throughout the treatment period up to the follow-up period or end of the study visit (Week 28)
Study: NCT05062759
Study Brief: Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Tezepelumab Patients received at least 1 injection of tezepelumab 210 mg administered subcutaneously every 4 weeks by APFS 0 None 0 35 14 35 View
Placebo Patients received at least 1 injection of placebo administered subcutaneously every 4 weeks by APFS 1 None 1 35 15 35 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Stab wound SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Acute sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Ear infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Viral upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Pharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 25.0 View
Skin laceration SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.0 View